drugset / Trial / NCT00206583

Efficacy and Safety Study of an Oral Contraceptive in Healthy Females

NCT00206583

Phase 3 Completed 499 enrolled Bayer
Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether the study drug is safe and effective in the prevention of pregnancies in a large group of volunteers.

Timeline

Start
2005-03
Primary completion
2007-06
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule Oral
Subject estradiol valerate Unknown Oral

Indications

No indication recorded.